A descriptive study of functions, symptoms, and perceived health state after radiotherapy for prostate cancer

European Journal of Oncology Nursing

Volumn 16, Issue 3, 2012, Pages 310-314

  Cameron, Sheila ^a   Springer, Colvin ^b   Fox Wasylyshyn, Susan ^a   El Masri, Maher M ^a  

^a UNIVERSITY OF WINDSOR   (Canada)

^b Centre Regional De Cancerologie De Windsor   (Canada)

Author keywords

Education; Perceived health state; Prostate cancer; Quality of life; Radiation treatment; Symptoms

Indexed keywords

AGED; ARTICLE; BLADDER DISEASE; CANADA; HEALTH SURVEY; HUMAN; MALE; PATHOPHYSIOLOGY; PROSPECTIVE STUDY; PROSTATE TUMOR; QUALITY OF LIFE; QUESTIONNAIRE; RECTUM DISEASE; SEXUAL DYSFUNCTION; STATISTICAL MODEL; TREATMENT OUTCOME;

AGED; HEALTH STATUS INDICATORS; HUMANS; LINEAR MODELS; MALE; ONTARIO; PROSPECTIVE STUDIES; PROSTATIC NEOPLASMS; QUALITY OF LIFE; QUESTIONNAIRES; RECTAL DISEASES; SEXUAL DYSFUNCTION, PHYSIOLOGICAL; TREATMENT OUTCOME; URINARY BLADDER DISEASES;

EID: 84861343772     PISSN: 14623889     EISSN: 15322122     Source Type: Journal    
DOI: 10.1016/j.ejon.2011.07.007     Document Type: Article

References (20)

1. Bellmunt J., Macia F., Malmusi D., Llorente J.A., Carles J., Lloreta J., et al. Impact of PSA implementation and combined radiation and hormonal therapy (RT + HT) on outcome of prostate cancer patients. European Journal of Cancer 2009, 45(16):2804-2809.
2. Blanker M.H., Bosch J.L., Groeneveld F.P., Bohnen A.M., Prins A., Thomas S., et al. Erectile and ejaculatory dysfunction in a community-based sample of men 50 to 78 years old: prevalence, concern, and relation to sexual activity. Urology 2001, 57(4):763-768.
3. Cheung K., Oemar M., Oppe M., Rabin R. User guide: basic information on how to use the EQ-5D. EuroQol Group 2010, 2010.
4. Choi M., Hung A.Y. Technological advances in radiation therapy for prostate cancer. Current Urology Reports 2010, 11(3):172-179.
5. Clark J.A., Inui T.S., Silliman R.A., Bokhour B.G., Krasnow S.H., Robinson R.A., et al. Patients' perceptions of quality of life after treatment for early prostate cancer. Journal of Clinical Oncology 2003, 21(20):3777-3784.
6. Eton D.T., Lepore S.J. Prostate cancer and health-related quality of life: a review of the literature. Psycho-oncology 2002, 11(4):307-326.
7. Guedea F., Ferrer M., Pera J., Aguilo F., Boladeras A., Suarez J.F., et al. Quality of life two years after radical prostatectomy, prostate brachytherapy or external beam radiotherapy for clinically localised prostate cancer: the Catalan Institute of Oncology/Bellvitge Hospital experience. Clinical and Translational Oncology 2009, 11(7):470-478.
8. Jemal A., Siegel R., Xu J., Ward E. Cancer statistics, 2010. CA A Cancer Journal for Clinicians 2010, 60(5):277-300.
9. Korfage I.J., Roobol M., de Koning H.J., Kirkels W.J., Schroder F.H., Essink-Bot M.L. Does " normal" aging imply urinary, bowel, and erectile dysfunction? A general population survey. Urology 2008, 72(1):3-9.
10. Leibel S.A., Fuks Z., Zelefsky M.J., Hunt M., Burman C.M., Mageras G.S., et al. Technological advances in external-beam radiation therapy for the treatment of localized prostate cancer. Seminars in Oncology 2003, 30(5):596-615.
11. Litwin M.S., Gore J.L., Kwan L., Brandeis J.M., Lee S.P., Withers H.R., et al. Quality of life after surgery, external beam irradiation, or brachytherapy for early-stage prostate cancer. Cancer 2007, 109(11):2239-2247.
12. Mangar S.A., Huddart R.A., Parker C.C., Dearnaley D.P., Khoo V.S., Horwich A. Technological advances in radiotherapy for the treatment of localised prostate cancer. European Journal of Cancer 2005, 41(6):908-921.
13. Pinkawa M., Asadpour B., Piroth M.D., Gagel B., Nussen S., Kehl M., et al. Health-related quality of life after permanent I-125 brachytherapy and conformal external beam radiotherapy for prostate cancer-a matched-pair comparison. Radiotherapy and Oncology 2009, 91(2):225-231.
14. Rogers L.Q., Courneya K.S., Paragi-Gururaja R., Markwell S.J., Imeokparia R. Lifestyle behaviors, obesity, and perceived health among men with and without a diagnosis of prostate cancer: a population-based, cross-sectional study. BMC Public Health 2008, 8:23.
15. Sanda M.G., Wei J.T., Litwin M.S. Scoring instructions for the expanded prostate cancer index composite (EPIC) Retrieved July 7, 2010, from. http://roadrunner.cancer.med.umich.edu/epic/EPIC-Scoring-2.2002.pdf.
16. Tanaka S.T., Ishii K., Demarco R.T., Pope J.Ct., Brock J.W., Hayward S.W. Variations in health-related quality of life in Japanese men who underwent iodine-125 permanent brachytherapy for localized prostate cancer. Journal of Urology 2010, 9(4):300-306.
17. Tangney M., Ahmad S., Collins S.A., O'Sullivan G.C. Gene therapy for prostate cancer. Postgraduate Medicine 2010, 122(3):166-180.
18. The American Cancer Society What are the key statistics about prostate cancer? (Publication. Retrieved October 07, 2010. http://www.cancer.org/Cancer/ProstateCancer/DetailedGuide/prostate-cancer-key-statistics.
19. The Canadian Cancer Society Prostate Cancer Statistics 2010.
20. Wei J.T., Dunn R.L., Litwin M.S., Sandler H.M., Sanda M.G. Development and validation of the expanded prostate cancer index composite (EPIC) for comprehensive assessment of health-related quality of life in men with prostate cancer. Urology 2000, 56(6):899-905.